Technical Analysis for OPTN - OptiNose, Inc.

Grade Last Price % Change Price Change
F 0.46 -10.29% -0.05
OPTN closed down 10.29 percent on Thursday, November 14, 2024, on 2.54 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Down 1 ATR about 19 hours ago
2x Volume Pace about 19 hours ago
1.5x Volume Pace about 19 hours ago
Down 10% about 19 hours ago
60 Minute Opening Range Breakdown about 19 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Pharmaceutical Disease Organ Systems Inflammation Allergy Respiratory Therapy Polyp Sinus Glucocorticoids Chronic Rhinosinusitis Corticosteroid Sinusitis Fluticasone Nasal Polyps Nasal Spray

Is OPTN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.1
52 Week Low 0.4412
Average Volume 496,432
200-Day Moving Average 1.09
50-Day Moving Average 0.74
20-Day Moving Average 0.71
10-Day Moving Average 0.66
Average True Range 0.07
RSI (14) 25.37
ADX 24.8
+DI 12.90
-DI 40.32
Chandelier Exit (Long, 3 ATRs) 0.61
Chandelier Exit (Short, 3 ATRs) 0.64
Upper Bollinger Bands 0.90
Lower Bollinger Band 0.52
Percent B (%b) -0.19
BandWidth 52.62
MACD Line -0.05
MACD Signal Line -0.02
MACD Histogram -0.0237
Fundamentals Value
Market Cap 51.1 Million
Num Shares 112 Million
EPS -0.38
Price-to-Earnings (P/E) Ratio -1.20
Price-to-Sales 2.09
Price-to-Book 24.26
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.59
Resistance 3 (R3) 0.60 0.56 0.57
Resistance 2 (R2) 0.56 0.53 0.56 0.56
Resistance 1 (R1) 0.51 0.51 0.49 0.50 0.55
Pivot Point 0.48 0.48 0.47 0.47 0.48
Support 1 (S1) 0.42 0.44 0.40 0.41 0.36
Support 2 (S2) 0.39 0.42 0.38 0.35
Support 3 (S3) 0.33 0.39 0.34
Support 4 (S4) 0.32